ClinicalTrials.Veeva

Menu

GORE EXCLUDER® Endoprosthesis - Low Permeability in Treatment of Abdominal Aortic Aneurysms

W.L. Gore & Associates logo

W.L. Gore & Associates

Status and phase

Completed
Phase 4

Conditions

Aortic Aneurysm, Abdominal

Treatments

Device: GORE EXCLUDER® Bifurcated Endoprosthesis-Low Permeability

Study type

Interventional

Funder types

Industry

Identifiers

NCT00593814
AAA 04-04

Details and patient eligibility

About

The purpose of this study is to evaluate the performance of the GORE EXCLUDER® Bifurcated Endoprosthesis-Low Permeability in the primary treatment of infrarenal abdominal aortic aneurysms.

Enrollment

139 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Infrarenal Abdominal Aortic Aneurysms less than 4.5 cm in diameter
  2. Anatomy meets EXCLUDER Bifurcated Endoprosthesis - Low Permeability specification criteria per Instructions for Use
  3. Access vessel able to receive 18 French introducer sheath
  4. Life expectancy > 2 years
  5. Appropriate candidate for endovascular repair
  6. Ability to comply with protocol requirements including follow-up
  7. 21 years of age or older, male or infertile female**

Exclusion criteria

  1. Mycotic or ruptured aneurysm
  2. Participating in another investigational device or drug study within one year
  3. Documented history of drug abuse within six months
  4. Myocardial infarction or cerebral vascular accident within six weeks
  5. Pulmonary insufficiency requiring chronic home oxygen or inability to ambulate due to pulmonary function
  6. Iliac anatomy that would require occlusion of both internal iliac arteries
  7. Planned occlusion or reimplantation of significant mesenteric or renal arteries
  8. Planned concomitant surgical procedure or previous major surgery within 30 days
  9. Previous prosthesis placement in the aorta or iliac arteries
  10. Degenerative connective tissue disease (e.g., Marfan's and Ehlers Danlos Syndrome)

Trial design

Primary purpose

Treatment

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems